Forgot your password?

Forgot your username?


BIO-CEO Wraps Up 19th Annual Investor Conference

Posted on 18 Feb 2017
Now in its 19th year, the BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies. With a mission to support industry-wide success, the conference offers a broad and unbiased

Marcum to Host 6th Annual Microcap Conference

Posted on 18 Feb 2017
The Marcum Microcap Conference is an annual highlight on the investment community calendar. Since its launch in 2012, this event has become a nationally recognized forum for publicly traded companies with less than $500 million in market capitalization to network with fund managers an

SafeHeal Medical’s Solution to Reshape Digestive Surgery

Posted on 31 Oct 2016
SafeHeal Medical is a company developing a breakthrough solution for patients undergoing colorectal surgery. Its product, the SafeHeal Colovac device, eliminates the traditional need for an artificial anus and related pouches through the protection of the digestive anastomosis during

Catalia Health’s Healthcare Robot Improves Patient Outcomes

Posted on 31 Oct 2016
Catalia Health, a San Francisco-based company, is garnering attention from the medtech industry with its healthcare robot. The “Mabu” is a personal healthcare companion aimed at providing assistance to patients suffering from chronic disease, while also collecting data for use by heal

Industry Leaders Outlook on the Future of Healthcare

Posted on 31 Oct 2016
BY: BRETT JOHNSON, EDITOR-IN-CHIEF “Value-driven” vs. “volume-driven” was the theme of a discussion between top management of the country’s important healthcare institutions. Leaders of Mayo Clinic, United Healthcare, IBM and Medtronic addressed over 2,000 medi

Progress on Antibe’s Non-Steroidal Anti-Inflammatory Drug

Posted on 15 Jun 2015
Results of additional testing have been recently announced by Antibe Therapeutics pertaining to the progress of the developmental procedures being conducted by the company for their ATB-346 drug. These recent validation data show further proof that ATB-346 can be effective even if adm

Wafergen’s Smartchip Mydesign Genomic Technology to be Employed by Procter & Gamble

Posted on 11 May 2015
Wafergen Biosystems and Procter & Gamble recently announced their industrial partnership that involves the latter utilizing the former’s specialized quantitative PCR System namely SmartChip MyDesign. Proctor & Gamble will make use of Wafergen’s product for researches involving

Cellular Biomedicine Group Joins Force With Huntsworth Health For KOL Advocacy On Clinical Research For Knee Osteoarthritis

Posted on 11 May 2015
Cellular Biomedicine Group, Inc. (CBMG) has took on Hunstworth Health to put in order a team of medical experts for a global KOL advocacy campaign for CBMG’s Rejoin clinical trials. The clinical trials are for Rejoin which is a human adipose-derived mesenchymal progenitor cell (haMPC)

Capnia Develop Cluster Headache Medicine with Partner Clinvest

Posted on 11 May 2015
A recently announced Memorandum of Understanding (MOU) between Capnia, Inc. and Clinvest, a Banyan Group, Inc. division, has brought about the formation of the collaboration between the two parties to develop a cure for cluster headache with the use of the former’s proprietary nasal C